Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress via Nrf2/ROS/PERK/CHOP Signaling Pathway to Attenuate Cisplatin Resistance in NSCLC
|更新时间:2025-04-18
|
Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress via Nrf2/ROS/PERK/CHOP Signaling Pathway to Attenuate Cisplatin Resistance in NSCLC
“According to the latest research report, Bu Zhong Yi Qi Tang regulates endoplasmic reticulum stress through the Nrf2/ROS/PERK/CHOP signaling pathway and improves cisplatin resistance in non-small cell lung cancer.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 10, Pages: 79-89(2025)
LI He,LIU Yuetong,HUANG Jingyi,et al.Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress via Nrf2/ROS/PERK/CHOP Signaling Pathway to Attenuate Cisplatin Resistance in NSCLC[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(10):79-89.
LI He,LIU Yuetong,HUANG Jingyi,et al.Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress via Nrf2/ROS/PERK/CHOP Signaling Pathway to Attenuate Cisplatin Resistance in NSCLC[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(10):79-89. DOI: 10.13422/j.cnki.syfjx.20242025.
Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress via Nrf2/ROS/PERK/CHOP Signaling Pathway to Attenuate Cisplatin Resistance in NSCLC